- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 6 x CO3: CARBONATE ION(Non-functional Binders)
CO3.3: 9 residues within 4Å:- Chain A: K.291, D.376, S.377, E.378, G.379, R.380, L.404, T.405
- Ligands: ZN.2
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.291, A:S.377, A:G.379, A:L.404
CO3.8: 9 residues within 4Å:- Chain B: K.291, D.376, S.377, E.378, G.379, R.380, L.404, T.405
- Ligands: ZN.10
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.378, B:G.379, B:R.380, B:R.380
CO3.15: 9 residues within 4Å:- Chain C: K.291, D.376, S.377, E.378, G.379, R.380, L.404, T.405
- Ligands: ZN.13
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:K.291, C:D.376, C:G.379, C:R.380
CO3.23: 9 residues within 4Å:- Chain D: K.291, D.376, S.377, E.378, G.379, R.380, L.404, T.405
- Ligands: ZN.22
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:R.380, D:R.380, D:L.404
CO3.30: 9 residues within 4Å:- Chain E: K.291, D.376, S.377, E.378, G.379, R.380, L.404, T.405
- Ligands: ZN.28
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:K.291, E:G.379, E:R.380, E:L.404
CO3.37: 8 residues within 4Å:- Chain F: K.291, D.376, S.377, E.378, G.379, R.380, L.404
- Ligands: ZN.36
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:R.380, F:R.380, F:L.404
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 8 residues within 4Å:- Chain A: Y.161, D.166, Y.209, S.212, A.216, K.504, P.505
- Chain C: Y.458
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:D.166, A:D.166, A:S.212, C:Y.458, C:Y.458
- Salt bridges: A:K.504
SO4.5: 7 residues within 4Å:- Chain A: I.447, N.448, E.449
- Chain F: S.116, E.117, A.118, Y.416
8 PLIP interactions:4 interactions with chain F, 4 interactions with chain A- Hydrogen bonds: F:E.117, F:E.117, F:Y.416, A:N.448, A:N.448, A:E.449
- Water bridges: F:S.116, A:E.449
SO4.11: 6 residues within 4Å:- Chain A: S.352, K.353
- Chain B: S.352, K.353
- Chain C: S.352, K.353
10 PLIP interactions:4 interactions with chain B, 4 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: B:S.352, B:S.352, B:K.353, C:S.352, C:S.352, C:K.353, A:S.352, A:K.353
- Salt bridges: B:K.353, C:K.353
SO4.16: 7 residues within 4Å:- Chain C: E.42, G.43, K.135, L.136, S.137, K.138
- Chain E: K.81
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain E- Hydrogen bonds: C:G.43, C:S.137
- Salt bridges: E:K.81
SO4.20: 5 residues within 4Å:- Chain C: P.306, G.307, S.308, M.309, I.310
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:G.307, C:S.308, C:S.308, C:S.308, C:M.309
- Water bridges: C:I.310
SO4.24: 7 residues within 4Å:- Chain A: F.73, F.82
- Chain D: Y.93, M.94, F.95, S.101, V.102
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:M.94, D:M.94, D:S.101, D:V.102
SO4.31: 6 residues within 4Å:- Chain C: F.73, N.78, K.81
- Chain E: Y.93, F.95, S.101
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain E- Hydrogen bonds: C:N.78, E:S.101
- Salt bridges: C:K.81
SO4.34: 6 residues within 4Å:- Chain D: S.352, K.353
- Chain E: S.352, K.353
- Chain F: S.352, K.353
7 PLIP interactions:2 interactions with chain E, 2 interactions with chain D, 3 interactions with chain F- Hydrogen bonds: E:S.352, E:K.353, D:S.352, D:K.353, F:S.352, F:K.353
- Salt bridges: F:K.353
- 12 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
1PE.6: 7 residues within 4Å:- Chain A: Y.20, N.21, H.25, F.206, K.237, L.238, Y.328
No protein-ligand interaction detected (PLIP)1PE.7: 17 residues within 4Å:- Chain A: K.291, D.296, K.303, G.307, S.308, M.309, M.313, F.315, D.316, T.403, L.404, T.405, G.406, L.409, A.494
- Ligands: ZN.1, ZN.2
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.303
- Water bridges: A:Y.410
1PE.12: 7 residues within 4Å:- Chain B: Y.20, H.25, F.206, L.234, K.237, L.238, Y.328
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:K.237, B:L.238
1PE.17: 6 residues within 4Å:- Chain C: Y.20, N.21, E.233, Q.236, K.237
- Ligands: 1PE.18
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:K.237
- Hydrogen bonds: C:K.237
1PE.18: 8 residues within 4Å:- Chain C: Y.20, N.21, H.25, F.206, K.237, L.238, Y.328
- Ligands: 1PE.17
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Y.328
1PE.19: 16 residues within 4Å:- Chain C: K.291, D.296, K.303, G.307, S.308, M.309, M.313, F.315, D.316, T.403, L.404, G.406, L.409, Y.410, A.494
- Ligands: ZN.13
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:K.303, C:D.316
1PE.25: 9 residues within 4Å:- Chain D: Y.20, N.21, H.25, F.206, L.234, K.237, L.238, Y.328
- Ligands: 1PE.26
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Y.328
1PE.26: 4 residues within 4Å:- Chain D: Y.20, E.233, K.237
- Ligands: 1PE.25
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:K.237
1PE.27: 16 residues within 4Å:- Chain D: K.291, D.296, K.303, G.307, S.308, M.313, F.315, D.316, T.403, L.404, T.405, G.406, L.409, A.494
- Ligands: ZN.21, ZN.22
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.303, D:D.316
1PE.32: 7 residues within 4Å:- Chain E: Y.20, N.21, H.25, F.206, K.237, L.238, Y.328
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:K.237, E:Y.328
1PE.33: 17 residues within 4Å:- Chain E: K.291, D.296, K.303, G.307, S.308, M.309, M.313, F.315, D.316, D.376, T.403, L.404, G.406, L.409, A.494
- Ligands: ZN.28, ZN.29
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:D.296, E:K.303
1PE.38: 17 residues within 4Å:- Chain F: K.291, D.296, K.303, G.307, S.308, M.309, M.313, F.315, D.316, T.403, L.404, T.405, G.406, L.409, A.494
- Ligands: ZN.35, ZN.36
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:K.303, F:G.307
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Koning-Ward, T.F. et al., Characterisation of a novel antimalarial agent targeting haemaglobin digestion that shows cross-species reactivity and excellent in vivo properties. Mbio (2024)
- Release Date
- 2024-04-24
- Peptides
- Leucine aminopeptidase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 6 x CO3: CARBONATE ION(Non-functional Binders)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 12 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Koning-Ward, T.F. et al., Characterisation of a novel antimalarial agent targeting haemaglobin digestion that shows cross-species reactivity and excellent in vivo properties. Mbio (2024)
- Release Date
- 2024-04-24
- Peptides
- Leucine aminopeptidase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F